Company profile

Chembio Diagnostics, Inc.

Industry
Medical Equipment Manufacturing
Employees
111
Headquarters
Medford, NY
Founded
1986
LinkedIn followers
7,623
Office locations
1

Chembio Diagnostics, Inc. company summary

Chembio Diagnostics, Inc. is a company in the Medical Equipment Manufacturing industry, headquartered in Medford, NY, founded in 1986. On LinkedIn the company has around 111 employees and 7,623 followers.

What technology does Chembio Diagnostics, Inc. use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Chembio Diagnostics, Inc.

About Chembio Diagnostics: Chembio is a leading point-of-care diagnostics company focused on creating fast actionable tests to diagnose diseases quickly and accurately, including STIs and COVID-19, enabling expedited treatment. Chembio tests are easy to use and provide results in approximately 15 minutes using some of the smallest sample sizes of fingertip blood, nasal swabs and other sample types. Chembio recently received FDA CLIA Waiver for the first rapid point-of-care combination test for HIV & Syphilis. Coupled with Chembio’s extensive scientific expertise, its novel DPP® technology offers broad market applications beyond infectious disease. Chembio’s products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. Learn more at www.chembio.com. About the DPP Rapid Test Platform: Chembio’s proprietary DPP® technology platform provides high-quality, rapid diagnostic results in 15 to 20 minutes using a small drop of blood from the fingertip or alternative samples. Through advanced multiplexing, the DPP platform can detect up to eight, distinct test results from a single patient sample, delivering greater clinical value than other rapid tests. For certain applications, Chembio’s easy-to-use, highly portable, battery-operated DPP Micro Reader optical analyzer then reports accurate results in approximately 15 seconds, making it well-suited for decentralized testing where real-time results enable patients to be clinically assessed while they are still on-site. Objective results produced by the DPP Micro Reader reduce the possibility of the types of human error that can be experienced in the visual interpretations required by many rapid tests.

Where is Chembio Diagnostics, Inc. located?

Chembio Diagnostics, Inc. lists 1 location.

Medford, NY, USHQ
3661 Horseblock Rd.

Compare companies similar to Chembio Diagnostics, Inc.

More companies in Medical Equipment Manufacturing.

CompanyIndustryEmployeesFoundedHeadquarters
Chembio Diagnostics, Inc.
chembio.com
Medical Equipment Manufacturing1111986Medford, NY
Boston Scientific
bostonscientific.com
Medical Equipment Manufacturing54,970-Marlborough, MA
BD
bd.com
Medical Equipment Manufacturing46,224-Franklin Lakes, New Jersey
Medical Equipment Manufacturing39,218-Deerfield, Illinois
Alcon
alcon.com
Medical Equipment Manufacturing27,667-Geneva, Switzerland
Smith+Nephew
smith-nephew.com
Medical Equipment Manufacturing19,271-Watford, Hertfordshire, GB
Zimmer Biomet EMEA
zimmerbiomet.com
Medical Equipment Manufacturing19,125-Warsaw, Indiana
Olympus Corporation
olympus-global.com
Medical Equipment Manufacturing13,7031919Shinjuku-ku, Tokyo
Intuitive
intuitive.com
Medical Equipment Manufacturing13,0911995California, 94086
Medical Equipment Manufacturing18,899-Northfield, IL
Medical Equipment Manufacturing14,1971958Irvine, CA

Frequently asked questions about Chembio Diagnostics, Inc.

What does Chembio Diagnostics, Inc. do?

About Chembio Diagnostics: Chembio is a leading point-of-care diagnostics company focused on creating fast actionable tests to diagnose diseases quickly and accurately, including STIs and COVID-19, enabling expedited treatment. Chembio tests are easy to use and provide results in approximately 15 minutes using some of the smallest sample sizes of fingertip blood, nasal swabs and other sample types. Chembio recently received FDA CLIA Waiver for the first rapid point-of-care combination test for HIV & Syphilis. Coupled with Chembio’s extensive scientific expertise, its novel DPP® technology offers broad market applications beyond infectious disease. Chembio’s products are sold globally, directly and through distributors, to hospitals and clinics, physician offices, clinical laboratories, public health organizations, government agencies, and consumers. Learn more at www.chembio.com. About the DPP Rapid Test Platform: Chembio’s proprietary DPP® technology platform provides high-quality, rapid diagnostic results in 15 to 20 minutes using a small drop of blood from the fingertip or alternative samples. Through advanced multiplexing, the DPP platform can detect up to eight, distinct test results from a single patient sample, delivering greater clinical value than other rapid tests. For certain applications, Chembio’s easy-to-use, highly portable, battery-operated DPP Micro Reader optical analyzer then reports accurate results in approximately 15 seconds, making it well-suited for decentralized testing where real-time results enable patients to be clinically assessed while they are still on-site. Objective results produced by the DPP Micro Reader reduce the possibility of the types of human error that can be experienced in the visual interpretations required by many rapid tests.

How many employees does Chembio Diagnostics, Inc. have?

Chembio Diagnostics, Inc. has around 111 employees on LinkedIn.

Where is Chembio Diagnostics, Inc. headquartered?

Chembio Diagnostics, Inc. is headquartered in Medford, NY.

When was Chembio Diagnostics, Inc. founded?

Chembio Diagnostics, Inc. was founded in 1986.

Build a lead list from companies like Chembio Diagnostics, Inc.

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.